Home > > > > Report Detail

Global Hemophilia Gene Therapy Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Publisher Name :
Date: 14-Feb-2019
No. of pages: 116

Hemophilia is a rare bleeding disorder in which the blood does not clot normally. Hemophilia is a monogenic disease (a disease that is caused by a genetic defect in a single gene). There are two types of hemophilia caused by mutations in genes that encode protein factors which help the blood clot and stop bleeding when blood vessels are injured. Individuals with hemophilia experience bleeding episodes after injuries and spontaneous bleeding episodes that often lead to joint disease such as arthritis. The most frequent forms of hemophilia affect males.

Scope of the Report:

About 80% of them have hemophilia A, which affects the clotting factor VIII. The second most common form, hemophilia B, is due to a deficiency of the clotting factor IX. Several biotechs are racing to launch the first gene therapy for hemophilia. Currently, uniQure in the Netherlands and Spark Therapeutics in the US have the most advanced programs. Spark scored a victory in December when it presented Phase I/II for its candidate SPK-9001. The gene therapy was able to reduce annual bleeding episodes by 97%, as compared to its competitor uniQure's candidate, AMT-060. However, uniQure has fought back. The company added a modification in its gene therapy that is known to increase clotting activity by 8- to 9- fold. This improved version has already been cleared to start a Phase III clinical trial in both Europe and the US.

Hemophilia B has traditionally been the main focus of biotechs, since most big pharma efforts were focused on the bigger hemophilia A market. In addition, applying gene therapy to hemophilia A is more challenging; The gene coding for the factor IX protein missing in hemophilia B is simply smaller than that for factor VIII missing in hemophilia A, and therefore easier to fit in the viral vectors used for gene delivery. US-based BioMarin is leading the development of a gene therapy. To overcome the size limit, the company has deleted a region from the factor VIII protein that is not necessary for clotting.

Hemophilia treatment is currently in the pre-clinical stage. And the multiple treatments that are underway might significantly improve the quality of life of patients with hemophilia, by getting rid of frequent infusions and hospital visits, and transitioning patients from severe to mild hemophilia.

The global Hemophilia Gene Therapy market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Hemophilia Gene Therapy.

Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.

This report studies the Hemophilia Gene Therapy market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Hemophilia Gene Therapy market by product type and applications/end industries.

Market Segment by Companies, this report covers

- Spark Therapeutics

- Ultragenyx

- Shire PLC

- Sangamo Therapeutics

- Bioverativ

- BioMarin

- uniQure

- Freeline Therapeutics

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Hemophilia A

- Hemophilia B

Market Segment by Applications, can be divided into

- Hemophilia A Gene Therapy

- Hemophilia B Gene Therapy

Global Hemophilia Gene Therapy Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Hemophilia Gene Therapy Market Overview
1.1 Product Overview and Scope of Hemophilia Gene Therapy
1.2 Classification of Hemophilia Gene Therapy by Types
1.2.1 Global Hemophilia Gene Therapy Revenue Comparison by Types (2019-2024)
1.2.2 Global Hemophilia Gene Therapy Revenue Market Share by Types in 2018
1.2.3 Hemophilia A
1.2.4 Hemophilia B
1.3 Global Hemophilia Gene Therapy Market by Application
1.3.1 Global Hemophilia Gene Therapy Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hemophilia A Gene Therapy
1.3.3 Hemophilia B Gene Therapy
1.4 Global Hemophilia Gene Therapy Market by Regions
1.4.1 Global Hemophilia Gene Therapy Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Hemophilia Gene Therapy Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Hemophilia Gene Therapy Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Hemophilia Gene Therapy Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Hemophilia Gene Therapy Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Hemophilia Gene Therapy Status and Prospect (2014-2024)
1.5 Global Market Size of Hemophilia Gene Therapy (2014-2024)
2 Manufacturers Profiles
2.1 Spark Therapeutics
2.1.1 Business Overview
2.1.2 Hemophilia Gene Therapy Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Spark Therapeutics Hemophilia Gene Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.2 Ultragenyx
2.2.1 Business Overview
2.2.2 Hemophilia Gene Therapy Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Ultragenyx Hemophilia Gene Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.3 Shire PLC
2.3.1 Business Overview
2.3.2 Hemophilia Gene Therapy Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Shire PLC Hemophilia Gene Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.4 Sangamo Therapeutics
2.4.1 Business Overview
2.4.2 Hemophilia Gene Therapy Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Sangamo Therapeutics Hemophilia Gene Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.5 Bioverativ
2.5.1 Business Overview
2.5.2 Hemophilia Gene Therapy Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Bioverativ Hemophilia Gene Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.6 BioMarin
2.6.1 Business Overview
2.6.2 Hemophilia Gene Therapy Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 BioMarin Hemophilia Gene Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.7 uniQure
2.7.1 Business Overview
2.7.2 Hemophilia Gene Therapy Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 uniQure Hemophilia Gene Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.8 Freeline Therapeutics
2.8.1 Business Overview
2.8.2 Hemophilia Gene Therapy Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Freeline Therapeutics Hemophilia Gene Therapy Revenue, Gross Margin and Market Share (2017-2018)
3 Global Hemophilia Gene Therapy Market Competition, by Players
3.1 Global Hemophilia Gene Therapy Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Hemophilia Gene Therapy Players Market Share
3.2.2 Top 10 Hemophilia Gene Therapy Players Market Share
3.3 Market Competition Trend
4 Global Hemophilia Gene Therapy Market Size by Regions
4.1 Global Hemophilia Gene Therapy Revenue and Market Share by Regions
4.2 North America Hemophilia Gene Therapy Revenue and Growth Rate (2014-2019)
4.3 Europe Hemophilia Gene Therapy Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Hemophilia Gene Therapy Revenue and Growth Rate (2014-2019)
4.5 South America Hemophilia Gene Therapy Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Hemophilia Gene Therapy Revenue and Growth Rate (2014-2019)
5 North America Hemophilia Gene Therapy Revenue by Countries
5.1 North America Hemophilia Gene Therapy Revenue by Countries (2014-2019)
5.2 USA Hemophilia Gene Therapy Revenue and Growth Rate (2014-2019)
5.3 Canada Hemophilia Gene Therapy Revenue and Growth Rate (2014-2019)
5.4 Mexico Hemophilia Gene Therapy Revenue and Growth Rate (2014-2019)
6 Europe Hemophilia Gene Therapy Revenue by Countries
6.1 Europe Hemophilia Gene Therapy Revenue by Countries (2014-2019)
6.2 Germany Hemophilia Gene Therapy Revenue and Growth Rate (2014-2019)
6.3 UK Hemophilia Gene Therapy Revenue and Growth Rate (2014-2019)
6.4 France Hemophilia Gene Therapy Revenue and Growth Rate (2014-2019)
6.5 Russia Hemophilia Gene Therapy Revenue and Growth Rate (2014-2019)
6.6 Italy Hemophilia Gene Therapy Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Hemophilia Gene Therapy Revenue by Countries
7.1 Asia-Pacific Hemophilia Gene Therapy Revenue by Countries (2014-2019)
7.2 China Hemophilia Gene Therapy Revenue and Growth Rate (2014-2019)
7.3 Japan Hemophilia Gene Therapy Revenue and Growth Rate (2014-2019)
7.4 Korea Hemophilia Gene Therapy Revenue and Growth Rate (2014-2019)
7.5 India Hemophilia Gene Therapy Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Hemophilia Gene Therapy Revenue and Growth Rate (2014-2019)
8 South America Hemophilia Gene Therapy Revenue by Countries
8.1 South America Hemophilia Gene Therapy Revenue by Countries (2014-2019)
8.2 Brazil Hemophilia Gene Therapy Revenue and Growth Rate (2014-2019)
8.3 Argentina Hemophilia Gene Therapy Revenue and Growth Rate (2014-2019)
8.4 Colombia Hemophilia Gene Therapy Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Hemophilia Gene Therapy by Countries
9.1 Middle East and Africa Hemophilia Gene Therapy Revenue by Countries (2014-2019)
9.2 Saudi Arabia Hemophilia Gene Therapy Revenue and Growth Rate (2014-2019)
9.3 UAE Hemophilia Gene Therapy Revenue and Growth Rate (2014-2019)
9.4 Egypt Hemophilia Gene Therapy Revenue and Growth Rate (2014-2019)
9.5 Nigeria Hemophilia Gene Therapy Revenue and Growth Rate (2014-2019)
9.6 South Africa Hemophilia Gene Therapy Revenue and Growth Rate (2014-2019)
10 Global Hemophilia Gene Therapy Market Segment by Type
10.1 Global Hemophilia Gene Therapy Revenue and Market Share by Type (2014-2019)
10.2 Global Hemophilia Gene Therapy Market Forecast by Type (2019-2024)
10.3 Hemophilia A Revenue Growth Rate (2014-2024)
10.4 Hemophilia B Revenue Growth Rate (2014-2024)
11 Global Hemophilia Gene Therapy Market Segment by Application
11.1 Global Hemophilia Gene Therapy Revenue Market Share by Application (2014-2019)
11.2 Hemophilia Gene Therapy Market Forecast by Application (2019-2024)
11.3 Hemophilia A Gene Therapy Revenue Growth (2014-2019)
11.4 Hemophilia B Gene Therapy Revenue Growth (2014-2019)
12 Global Hemophilia Gene Therapy Market Size Forecast (2019-2024)
12.1 Global Hemophilia Gene Therapy Market Size Forecast (2019-2024)
12.2 Global Hemophilia Gene Therapy Market Forecast by Regions (2019-2024)
12.3 North America Hemophilia Gene Therapy Revenue Market Forecast (2019-2024)
12.4 Europe Hemophilia Gene Therapy Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Hemophilia Gene Therapy Revenue Market Forecast (2019-2024)
12.6 South America Hemophilia Gene Therapy Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Hemophilia Gene Therapy Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Hemophilia Gene Therapy Picture
Table Product Specifications of Hemophilia Gene Therapy
Table Global Hemophilia Gene Therapy and Revenue (Million USD) Market Split by Product Type
Figure Global Hemophilia Gene Therapy Revenue Market Share by Types in 2018
Figure Hemophilia A Picture
Figure Hemophilia B Picture
Table Global Hemophilia Gene Therapy Revenue (Million USD) by Application (2014-2024)
Figure Hemophilia Gene Therapy Revenue Market Share by Applications in 2018
Figure Hemophilia A Gene Therapy Picture
Figure Hemophilia B Gene Therapy Picture
Table Global Market Hemophilia Gene Therapy Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Hemophilia Gene Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Hemophilia Gene Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Hemophilia Gene Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Hemophilia Gene Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Hemophilia Gene Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Hemophilia Gene Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Table Spark Therapeutics Basic Information, Manufacturing Base and Competitors
Table Spark Therapeutics Hemophilia Gene Therapy Type and Applications
Table Spark Therapeutics Hemophilia Gene Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Ultragenyx Basic Information, Manufacturing Base and Competitors
Table Ultragenyx Hemophilia Gene Therapy Type and Applications
Table Ultragenyx Hemophilia Gene Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Shire PLC Basic Information, Manufacturing Base and Competitors
Table Shire PLC Hemophilia Gene Therapy Type and Applications
Table Shire PLC Hemophilia Gene Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Sangamo Therapeutics Basic Information, Manufacturing Base and Competitors
Table Sangamo Therapeutics Hemophilia Gene Therapy Type and Applications
Table Sangamo Therapeutics Hemophilia Gene Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Bioverativ Basic Information, Manufacturing Base and Competitors
Table Bioverativ Hemophilia Gene Therapy Type and Applications
Table Bioverativ Hemophilia Gene Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table BioMarin Basic Information, Manufacturing Base and Competitors
Table BioMarin Hemophilia Gene Therapy Type and Applications
Table BioMarin Hemophilia Gene Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table uniQure Basic Information, Manufacturing Base and Competitors
Table uniQure Hemophilia Gene Therapy Type and Applications
Table uniQure Hemophilia Gene Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Freeline Therapeutics Basic Information, Manufacturing Base and Competitors
Table Freeline Therapeutics Hemophilia Gene Therapy Type and Applications
Table Freeline Therapeutics Hemophilia Gene Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Global Hemophilia Gene Therapy Revenue (Million USD) by Players (2014-2019)
Table Global Hemophilia Gene Therapy Revenue Share by Players (2014-2019)
Figure Global Hemophilia Gene Therapy Revenue Share by Players in 2017
Figure Global Hemophilia Gene Therapy Revenue Share by Players in 2018
Figure Global Top 5 Players Hemophilia Gene Therapy Revenue Market Share in 2018
Figure Global Top 10 Players Hemophilia Gene Therapy Revenue Market Share in 2018
Figure Global Hemophilia Gene Therapy Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Hemophilia Gene Therapy Revenue (Million USD) by Regions (2014-2019)
Table Global Hemophilia Gene Therapy Revenue Market Share by Regions (2014-2019)
Figure Global Hemophilia Gene Therapy Revenue Market Share by Regions (2014-2019)
Figure Global Hemophilia Gene Therapy Revenue Market Share by Regions in 2018
Figure North America Hemophilia Gene Therapy Revenue and Growth Rate (2014-2019)
Figure Europe Hemophilia Gene Therapy Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Hemophilia Gene Therapy Revenue and Growth Rate (2014-2019)
Figure South America Hemophilia Gene Therapy Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Hemophilia Gene Therapy Revenue and Growth Rate (2014-2019)
Table North America Hemophilia Gene Therapy Revenue by Countries (2014-2019)
Table North America Hemophilia Gene Therapy Revenue Market Share by Countries (2014-2019)
Figure North America Hemophilia Gene Therapy Revenue Market Share by Countries (2014-2019)
Figure North America Hemophilia Gene Therapy Revenue Market Share by Countries in 2018
Figure USA Hemophilia Gene Therapy Revenue and Growth Rate (2014-2019)
Figure Canada Hemophilia Gene Therapy Revenue and Growth Rate (2014-2019)
Figure Mexico Hemophilia Gene Therapy Revenue and Growth Rate (2014-2019)
Table Europe Hemophilia Gene Therapy Revenue (Million USD) by Countries (2014-2019)
Figure Europe Hemophilia Gene Therapy Revenue Market Share by Countries (2014-2019)
Figure Europe Hemophilia Gene Therapy Revenue Market Share by Countries in 2018
Figure Germany Hemophilia Gene Therapy Revenue and Growth Rate (2014-2019)
Figure UK Hemophilia Gene Therapy Revenue and Growth Rate (2014-2019)
Figure France Hemophilia Gene Therapy Revenue and Growth Rate (2014-2019)
Figure Russia Hemophilia Gene Therapy Revenue and Growth Rate (2014-2019)
Figure Italy Hemophilia Gene Therapy Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Hemophilia Gene Therapy Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Hemophilia Gene Therapy Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Hemophilia Gene Therapy Revenue Market Share by Countries in 2018
Figure China Hemophilia Gene Therapy Revenue and Growth Rate (2014-2019)
Figure Japan Hemophilia Gene Therapy Revenue and Growth Rate (2014-2019)
Figure Korea Hemophilia Gene Therapy Revenue and Growth Rate (2014-2019)
Figure India Hemophilia Gene Therapy Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Hemophilia Gene Therapy Revenue and Growth Rate (2014-2019)
Table South America Hemophilia Gene Therapy Revenue by Countries (2014-2019)
Table South America Hemophilia Gene Therapy Revenue Market Share by Countries (2014-2019)
Figure South America Hemophilia Gene Therapy Revenue Market Share by Countries (2014-2019)
Figure South America Hemophilia Gene Therapy Revenue Market Share by Countries in 2018
Figure Brazil Hemophilia Gene Therapy Revenue and Growth Rate (2014-2019)
Figure Argentina Hemophilia Gene Therapy Revenue and Growth Rate (2014-2019)
Figure Colombia Hemophilia Gene Therapy Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Hemophilia Gene Therapy Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Hemophilia Gene Therapy Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Hemophilia Gene Therapy Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Hemophilia Gene Therapy Revenue Market Share by Countries in 2018
Figure Saudi Arabia Hemophilia Gene Therapy Revenue and Growth Rate (2014-2019)
Figure UAE Hemophilia Gene Therapy Revenue and Growth Rate (2014-2019)
Figure Egypt Hemophilia Gene Therapy Revenue and Growth Rate (2014-2019)
Figure Nigeria Hemophilia Gene Therapy Revenue and Growth Rate (2014-2019)
Figure South Africa Hemophilia Gene Therapy Revenue and Growth Rate (2014-2019)
Table Global Hemophilia Gene Therapy Revenue (Million USD) by Type (2014-2019)
Table Global Hemophilia Gene Therapy Revenue Share by Type (2014-2019)
Figure Global Hemophilia Gene Therapy Revenue Share by Type (2014-2019)
Figure Global Hemophilia Gene Therapy Revenue Share by Type in 2019
Table Global Hemophilia Gene Therapy Revenue Forecast by Type (2019-2024)
Figure Global Hemophilia Gene Therapy Market Share Forecast by Type (2019-2024)
Figure Global Hemophilia A Revenue Growth Rate (2014-2019)
Figure Global Hemophilia B Revenue Growth Rate (2014-2019)
Table Global Hemophilia Gene Therapy Revenue by Application (2014-2019)
Table Global Hemophilia Gene Therapy Revenue Share by Application (2014-2019)
Figure Global Hemophilia Gene Therapy Revenue Share by Application (2014-2019)
Figure Global Hemophilia Gene Therapy Revenue Share by Application in 2019
Table Global Hemophilia Gene Therapy Revenue Forecast by Application (2019-2024)
Figure Global Hemophilia Gene Therapy Market Share Forecast by Application (2019-2024)
Figure Global Hemophilia A Gene Therapy Revenue Growth Rate (2014-2019)
Figure Global Hemophilia B Gene Therapy Revenue Growth Rate (2014-2019)
Figure Global Hemophilia Gene Therapy Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Hemophilia Gene Therapy Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Hemophilia Gene Therapy Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Hemophilia Gene Therapy Revenue Market Forecast (2019-2024)
Figure Europe Hemophilia Gene Therapy Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Hemophilia Gene Therapy Revenue Market Forecast (2019-2024)
Figure South America Hemophilia Gene Therapy Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Hemophilia Gene Therapy Revenue Market Forecast (2019-2024)
  • Global Gene Therapy Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 111
    According to our LPI (LP Information) latest study, the global Gene Therapy market size was valued at US$ 6923.7 million in 2023. With growing demand in downstream market, the Gene Therapy is forecast to a readjusted size of US$ 40340 million by 2030 with a CAGR of 28.6% during review period. The research report highlights the growth potential of the global Gene Therapy market. Gene Therapy are expected to show stable growth in the future market. However, product differentiation, reducin......
  • Global Hemophilia Gene Therapy Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90
    According to our LPI (LP Information) latest study, the global Hemophilia Gene Therapy market size was valued at US$ million in 2023. With growing demand in downstream market, the Hemophilia Gene Therapy is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Hemophilia Gene Therapy market. Hemophilia Gene Therapy are expected to show stable growth in the future market. However, produc......
  • Global Cell and Gene Therapy CDMO Market (2024 Edition): Analysis By Type (Cell Therapy, Gene Therapy, Gene-modified Cell Therapies), Application (Clinical, Pre-clinical), Indication, By Region, By Country: Market Insights and Forecast (2024-2029)
    Published: 01-Jan-2024        Price: US 2450 Onwards        Pages: 260
    Executive Summary Azoth Analytics has released a research report titled "Global Cell and Gene Therapy CDMO Market (2024 Edition)" which provides a complete analysis of the Global Cell and Gene Therapy CDMO Market industry in terms of market segmentation by Type (Cell Therapy, Gene Therapy, Gene-modified Cell Therapies), Application (Clinical, Pre-clinical), Indication (Oncology Diseases, Infectious Diseases, Neurological Disorder, Others) for the historical period of 2019-2022, es......
  • Global Hemophilia Gene Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 88
    According to our (Global Info Research) latest study, the global Hemophilia Gene Therapy market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. Hemophilia is a rare bleeding disorder in which the blood does not clot normally. Hemophilia is a monogenic disease (a disease that is caused by a genetic defect in a single gene). There are two types of hemophilia caused by mutations in genes that encode pr......
  • Global Gene Expression Analysis Market Status and Outlook 2023-2028
    Published: 26-Dec-2023        Price: US 3160 Onwards        Pages: 102
    Gene expression analyses study the occurrence or activity of the formation of a gene product from its coding gene. It is a sensitive indicator of biological activity wherein a changing gene expression pattern is reflected in a change of biological process. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This ......
  • Global Gene Expression Analysis Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 125
    Market Overview of Global Gene Expression Analysis market: According to our latest research, the global Gene Expression Analysis market looks promising in the next 5 years. As of 2022, the global Gene Expression Analysis market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global......
  • Global Animal Genetics Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 120
    Report Overview: Animal Genetics is a branch of genetics that studies heredity and variation chiefly in farm animals but also in domestic and wild animals. It is based on general genetic principles and concepts, and it mainly uses the hybrid, cytological, population, ontogenetic, mathematical-statistical, and twin methods of general genetics. Animal breeding or genetics is the area of science where experts are trying to steer the frequency of certain genes by combining the most super......
  • Global Animal Genetics Market Status and Outlook 2023-2028
    Published: 24-Nov-2023        Price: US 3160 Onwards        Pages: 105
    Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......
  • Gene Therapy Collaboration and Licensing Deals 2016-2023
    Published: 01-Nov-2023        Price: US 3995 Onwards        Pages: 450
    Gene Therapy Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the gene therapy deals entered into by the worlds leading biopharma companies. Fully revised and updated, the report provides details of gene therapy deals from 2016 to 2023. The report provides a detailed understanding and analysis of how and why companies enter gene therapy deals. These deals tend to be multicomponent, starting with collaborative R&D, and ......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs